Supporting this hypothesis, the gain-of-function mutation P1069Q, located adjacent to a CHS density, increases TRPM3 sensitivity and is associated with developmental and epileptic encephalopathies (Extended data Fig. 11b) 4–6. This evidence concerns the gene TRPM3 and Epileptic encephalopathy.